These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 16835334)

  • 1. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
    Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
    Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Negative Anti-
    Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
    Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
    Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
    Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
    Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.